News

Innovation has its phases. So does procurement. The challenge is to synchronise them.

Endoart SA, a Swiss company which develops medical devices for the obese, said it has raised CHF13.5 million ($10.5 million) in a series C financing from venture capital funds for product development and clinical trials.

The European University Association presents a vision for universities, with a few pointers to issues in knowledge transfer.

Johnson & Johnson's Corporate Office of Science & Technology (COSAT) has agreed to fund a research programme on hearing loss conduced by University College London's (UCL) Ear Institute under a partnership between the pharmaceutical giant and RNID, a non-profit organisation for the hearing impaired in the UK.

Chroma Therapeutics Ltd raised £30 million in a third private round, giving the chromatin specialist funding for the next three years and enabling it to advance the lead programme through Phase II clinical studies and bring two further products into the clinic.

There is more to smart government spending than just getting value for money. How about supporting innovation too?

More and more universities are desperate to show that they have a positive effect on the local economy. Here's one from the US.

Lots of buzz preceded what was billed as the world's first live, multi-lot technology patent auction on April 6, but reality failed to meet expectations for many of the inventors who put up 400-plus patents for sale.

Israeli researchers have invented software to “freeze” an image of the human heart in order to facilitate catheter navigation. They are now looking for either an investment or a licensing deal for the technology.

After finding nothing wrong with the specifics of the preclinical data, the product, or how the trial was conducted, the UK Medicines and Healthcare Products Regulatory Agency has ordered an investigation to changes in clinical trials procedures.